These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21730116)

  • 21. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
    Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK
    Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
    Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL
    Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
    Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
    Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine.
    Edaye S; Tazoo D; Bohle DS; Georges E
    Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake.
    Bray PG; Hawley SR; Ward SA
    Mol Pharmacol; 1996 Dec; 50(6):1551-8. PubMed ID: 8967977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
    Nqoro X; Aderibigbe BA
    Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum.
    Agarwal D; Singh S; Gupta RD; Awasthi SK
    Acta Trop; 2019 Nov; 199():105109. PubMed ID: 31351071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.
    Basco LK; Ringwald P
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1391-4. PubMed ID: 12654675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance.
    Dubar F; Egan TJ; Pradines B; Kuter D; Ncokazi KK; Forge D; Paul JF; Pierrot C; Kalamou H; Khalife J; Buisine E; Rogier C; Vezin H; Forfar I; Slomianny C; Trivelli X; Kapishnikov S; Leiserowitz L; Dive D; Biot C
    ACS Chem Biol; 2011 Mar; 6(3):275-87. PubMed ID: 21162558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis, and Evaluation of Novel Ferroquine and Phenylequine Analogues as Potential Antiplasmodial Agents.
    Jacobs L; de Kock C; de Villiers KA; Smith PJ; Smith VJ; van Otterlo WA; Blackie MA
    ChemMedChem; 2015 Dec; 10(12):2099-110. PubMed ID: 26447782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.
    Daher W; Pelinski L; Klieber S; Sadoun F; Meunier V; Bourrié M; Biot C; Guillou F; Fabre G; Brocard J; Fraisse L; Maffrand JP; Khalife J; Dive D
    Drug Metab Dispos; 2006 Apr; 34(4):667-82. PubMed ID: 16415117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, cytotoxicity and antimalarial activity of ferrocenyl amides of 4-aminoquinolines.
    N'Da DD; Breytenbach JC; Smith PJ; Lategan C
    Arzneimittelforschung; 2010; 60(10):627-35. PubMed ID: 21125814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum.
    Basco LK; Le Bras J
    Am J Trop Med Hyg; 1993 Jan; 48(1):120-5. PubMed ID: 8427380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses.
    Hocart SJ; Liu H; Deng H; De D; Krogstad FM; Krogstad DJ
    Antimicrob Agents Chemother; 2011 May; 55(5):2233-44. PubMed ID: 21383099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Trianty L; Kenangalem E; Noviyanti R; Campo B; Poespoprodjo JR; Möhrle JJ; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6117-24. PubMed ID: 26195523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
    Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
    Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro.
    Randrianarivelojosia M; Raharimalala LA; Randrianasolo L; Ratsimbasoa A; Rason MA; Ariey F; Jambou R
    Ann Trop Med Parasitol; 2001 Apr; 95(3):237-43. PubMed ID: 11339883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.